Press Releases

September 17, 2019
Askbio Acquires Assets from RoverMed BioSciences, Adds Nanotechnology Precision to Delivery of AAV Gene Therapeutics

August 27, 2019
Viralgen Receives cGMP Certification from European Medicines Agency

August 22, 2019
AskBio Applauds Pfizer’s Continuing Investments in Gene Therapy

August 13, 2019
AskBio Acquires Synpromics Ltd. and Expands its Gene Therapy Technology Portfolio

August 07, 2019
Selecta Biosciences Combines ImmTOR™ Platform with AskBio’s Industry-Leading Gene Therapy Platform in Strategic Partnership

July 02, 2019
AskBio’s Perspective on Pfizer’s 1b Clinical Trial Results on Duchenne MD Gene

May 30, 2019
Newly Approved Spinal Muscular Atrophy Gene Therapy, Zolgensma®, Validates AskBio Gene Therapy Platform

April 11, 2019
AskBio Partners with TPG and Vida Ventures

January 22, 2019
First Patient Dosed with Gene Therapy in Phase 1/2 Study of ACTUS-101 in Patients with Pompe Disease

April 25, 2018
Asklepios BioPharmaceutical, Inc. Announces Former Portfolio Company’s Preclinical Asset for Duchenne Muscular Dystrophy Has Advanced into the Clinic

December 14, 2017
Asklepios BioPharmaceutical, Inc. Launches New Portfolio Company – Actus Therapeutics, Inc.

October 17, 2017
AskBio and Columbus Venture Partners Launch Gene Therapy Company Viralgen

September 26, 2017
NanoCor Announces New Data on Congestive Heart Failure Gene Therapy

August 1, 2016
Pfizer Acquires Bamboo Therapeutics

April 20, 2016
Nanocor Gets IND Acceptance for Carfostin

April 02, 2014
Baxter Acquires Chatham Therapeutics

September 13, 2010
Pfizer Licencces Hep C Technology from AskBIO

January 20, 2009
ALS Therapy Development Institute and AskBio Announce Collaboration Targeting Lou Gehrig Disease

September 10, 2007
Medtronic and NanoCor Form Partnership